- Home
- HRMY vs BWLP Comparison
HRMY vs BWLP Comparison
Compare HRMY & BWLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRMY
- BWLP
- Stock Information
- Founded
- HRMY 2017
- BWLP 1935
- Country
- HRMY United States
- BWLP Singapore
- Employees
- HRMY N/A
- BWLP N/A
- Industry
- HRMY Biotechnology: Pharmaceutical Preparations
- BWLP Marine Transportation
- Sector
- HRMY Health Care
- BWLP Consumer Discretionary
- Exchange
- HRMY Nasdaq
- BWLP Nasdaq
- Market Cap
- HRMY 2.0B
- BWLP 1.6B
- IPO Year
- HRMY 2020
- BWLP N/A
- Fundamental
- Price
- HRMY $32.16
- BWLP $12.50
- Analyst Decision
- HRMY Strong Buy
- BWLP
- Analyst Count
- HRMY 9
- BWLP 0
- Target Price
- HRMY $54.22
- BWLP N/A
- AVG Volume (30 Days)
- HRMY 620.8K
- BWLP 428.2K
- Earning Date
- HRMY 08-05-2025
- BWLP 08-27-2025
- Dividend Yield
- HRMY N/A
- BWLP 13.60%
- EPS Growth
- HRMY 13.13
- BWLP N/A
- EPS
- HRMY 2.62
- BWLP 1.86
- Revenue
- HRMY $744,852,000.00
- BWLP $3,387,328,000.00
- Revenue This Year
- HRMY $20.10
- BWLP N/A
- Revenue Next Year
- HRMY $18.01
- BWLP $2.04
- P/E Ratio
- HRMY $12.27
- BWLP $7.23
- Revenue Growth
- HRMY 20.62
- BWLP 9.53
- 52 Week Low
- HRMY $26.47
- BWLP $7.86
- 52 Week High
- HRMY $41.61
- BWLP $19.36
- Technical
- Relative Strength Index (RSI)
- HRMY 43.25
- BWLP 65.89
- Support Level
- HRMY $31.70
- BWLP $11.58
- Resistance Level
- HRMY $33.69
- BWLP $12.18
- Average True Range (ATR)
- HRMY 0.89
- BWLP 0.30
- MACD
- HRMY -0.10
- BWLP 0.01
- Stochastic Oscillator
- HRMY 37.30
- BWLP 97.87
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
About BWLP BW LPG Limited Common Shares
BW LPG Ltd is an LPG shipping. It uses pioneering technology to power its vessels with cleaner-burning liquefied petroleum gas (LPG) and invest in R&D to take towards a zero-carbon future. The company is organized into two main segments: The shipping segment and the product services segment which buy and sell liquid petroleum gas and deliver it to customers. It generates the majority of its revenue from the shipping segment.